Search in:

Therapeutics and Clinical Risk Management Volume 10, 2014 - Issue

Submit an article Journal homepage

Open access

147

Views

CrossRef citations to date

Altmetric

Review

Therapeutic implications of Epstein–Barr virus infection for the treatment of nasopharyngeal carcinoma

Susanna Hilda Hutajulu1 Department of Internal Medicine, Faculty of Medicine Universitas Gadjah Mada/Dr Sardjito General Hospital, Yogyakarta, IndonesiaCorrespondence[email protected]

Johan Kurnianda1 Department of Internal Medicine, Faculty of Medicine Universitas Gadjah Mada/Dr Sardjito General Hospital, Yogyakarta, Indonesia

I Bing Tan2 Department of Ear, Nose and Throat, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands;3 Department of Ear, Nose and Throat, Faculty of Medicine Universitas Gadjah Mada/Dr Sardjito General Hospital, Yogyakarta, Indonesia

Jaap M Middeldorp4 Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands

Pages 721-736 | Published online: 05 Sep 2014

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (36)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (36)

Diógenes Germano Fornel, Túlio Morandin Ferrisse, Analú Barros de Oliveira & Carla Raquel Fontana. (2023) Photodynamic Therapy Can Modulate the Nasopharyngeal Carcinoma Microenvironment Infected with the Epstein–Barr Virus: A Systematic Review and Meta-Analysis. Biomedicines 11:5, pages 1344.
Crossref

Kevin Dzobo. (2021) The Role of Viruses in Carcinogenesis and Molecular Targeting: From Infection to Being a Component of the Tumor Microenvironment. OMICS: A Journal of Integrative Biology 25:6, pages 358-371.
Crossref

. 2021. Systems Immunology and Infection Microbiology. Systems Immunology and Infection Microbiology 603 645 .

Stephanie Pei Tung Yiu, Mike Dorothea, Kwai Fung Hui & Alan Kwok Shing Chiang. (2020) Lytic Induction Therapy against Epstein–Barr Virus-Associated Malignancies: Past, Present, and Future. Cancers 12:8, pages 2142.
Crossref

Angela Kwok-Fung Lo, Christopher W. Dawson, Hong Lok Lung, Ka-Leung Wong & Lawrence S. Young. (2020) The Therapeutic Potential of Targeting BARF1 in EBV-Associated Malignancies. Cancers 12:7, pages 1940.
Crossref

Nihel Ammous-Boukhris, Amor Mosbah, Wajdi Ayadi, Emna Sahli, Soizic Chevance, Arnaud Bondon, Ali Gargouri, Michele Baudy-Floc’h & Raja Mokdad-Gargouri. (2019) B1.12: a novel peptide interacting with the extracellular loop of the EBV oncoprotein LMP1. Scientific Reports 9:1.
Crossref

Honglin Chen, Mingfang Ji, Jing Feng Zong, Josephine Mun-Yee Ko, Wei Dai & Maria Li Lung. 2019. Nasopharyngeal Carcinoma. Nasopharyngeal Carcinoma 129 153 .

Cheng-Wei Li, Bo-Ren Jheng & Bor-Sen Chen. (2018) Investigating genetic-and-epigenetic networks, and the cellular mechanisms occurring in Epstein–Barr virus-infected human B lymphocytes via big data mining and genome-wide two-sided NGS data identification. PLOS ONE 13:8, pages e0202537.
Crossref

Yiqi Cai, Yiling Song, Danwei Cen, Chanqiong Zhang, Shanshan Mao, Xiaoxian Ye, Yirong Xiong, Pengfei Jiang, Jun Chen, Xiangyang Xue, Lifang Zhang & Guanbao Zhu. (2018) Novel ELISA for serodiagnosis of nasopharyngeal carcinoma based on a B cell epitope of Epstein‑Barr virus latent membrane protein 2. Oncology Letters.
Crossref

Octavia Ramayanti, Mitch Brinkkemper, Sandra Verkuijlen, Leni Ritmaleni, Mei Go & Jaap Middeldorp. (2018) Curcuminoids as EBV Lytic Activators for Adjuvant Treatment in EBV-Positive Carcinomas. Cancers 10:4, pages 89.
Crossref

Kathy Shair, Akhil Reddy & Vaughn Cooper. (2018) New Insights from Elucidating the Role of LMP1 in Nasopharyngeal Carcinoma. Cancers 10:4, pages 86.
Crossref

Kit-San Yuen, Zhong-Min Wang, Nok-Hei Mickey Wong, Zhi-Qian Zhang, Tsz-Fung Cheng, Wai-Yin Lui, Chi-Ping Chan & Dong-Yan Jin. (2018) Suppression of Epstein-Barr virus DNA load in latently infected nasopharyngeal carcinoma cells by CRISPR/Cas9. Virus Research 244, pages 296-303.
Crossref

Minglian Wang, Lindsey M. Hutt-Fletcher & Yi Zeng. 2018. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.

Zlata Novalić, Sandra A. W. M. Verkuijlen, Mariska Verlaan, Jos L. H. Eersels, Inge de Greeuw, Carla F. M. Molthoff, Jaap M. Middeldorp & Astrid E. Greijer. (2017) Cytolytic virus activation therapy and treatment monitoring for Epstein-Barr virus associated nasopharyngeal carcinoma in a mouse tumor model. Journal of Medical Virology 89:12, pages 2207-2216.
Crossref

Uyen Mui, Christopher Haley & Stephen Tyring. (2017) Viral Oncology: Molecular Biology and Pathogenesis. Journal of Clinical Medicine 6:12, pages 111.
Crossref

X. Shen, J. Yuan, M. Zhang, W. Li, B. Ni, Y. Wu, L. Jiang, W. Fan & Z. Tian. (2017) The increased expression of TCF3 is correlated with poor prognosis in Chinese patients with nasopharyngeal carcinoma. Clinical Otolaryngology 42:4, pages 824-830.
Crossref

Sin-Yeang Teow & Suat-Cheng Peh. 2017. Novel Implications of Exosomes in Diagnosis and Treatment of Cancer and Infectious Diseases. Novel Implications of Exosomes in Diagnosis and Treatment of Cancer and Infectious Diseases.

Richard J. Kraus, Xianming Yu, Blue-leaf A. Cordes, Saraniya Sathiamoorthi, Tawin Iempridee, Dhananjay M. Nawandar, Shidong Ma, James C. Romero-Masters, Kyle G. McChesney, Zhen Lin, Kathleen R. Makielski, Denis L. Lee, Paul F. Lambert, Eric C. Johannsen, Shannon C. Kenney & Janet E. Mertz. (2017) Hypoxia-inducible factor-1α plays roles in Epstein-Barr virus’s natural life cycle and tumorigenesis by inducing lytic infection through direct binding to the immediate-early BZLF1 gene promoter. PLOS Pathogens 13:6, pages e1006404.
Crossref

Ya Cao. (2017) EBV based cancer prevention and therapy in nasopharyngeal carcinoma. npj Precision Oncology 1:1.
Crossref

Hailiang Li, Chaoping Fu, Xiangwan Miao, Quanming Li, Juan Zhang, Huikang Yang, Tao Liu, Xi Chen & Minqiang Xie. (2017) Multifunctional magnetic co-delivery system coated with polymer mPEG-PLL-FA for nasopharyngeal cancer targeted therapy and MR imaging. Journal of Biomaterials Applications 31:8, pages 1169-1181.
Crossref

Bo-Yi Li, Yi Luo, Wen-Si Zhao, Lu Zhang, Han-Jing Zhou, Yu-Chun Zou & Tao Zhang. (2017) MicroRNA-210 negatively regulates the radiosensitivity of nasopharyngeal carcinoma cells. Molecular Medicine Reports 16:2, pages 1401-1408.
Crossref

Adel F. Al-Kholy, Omminea A. Abdullah, Mamdouh Z. Abadier, Manal M. Hassaan, Mohamed F. Shindy, Dalia M. Nor El-Dien & Ali Hasaneen. (2016) Pre-treatment serum inflammatory cytokines as survival predictors of patients with nasopharyngeal carcinoma receiving chemoradiotherapy. Molecular and Clinical Oncology 5:6, pages 811-816.
Crossref

Yan Huang, Wenhua Liang, Yunpeng Yang, Liping Zhao, Hongyun Zhao, Xuan Wu, Yuanyuan Zhao, Yang Zhang & Li Zhang. (2016) Phase I/II dose-finding study of nanoparticle albumin-bound paclitaxel (nab®-Paclitaxel) plus Cisplatin as Treatment for Metastatic Nasopharyngeal Carcinoma. BMC Cancer 16:1.
Crossref

Nihel Ammous-Boukhris, Amor Mosbah, Emna Sahli, Wajdi Ayadi, Boutheina Hadhri-Guiga, Ameur Chérif, Ali Gargouri & Raja Mokdad-Gargouri. (2016) Phage-display screening identifies LMP1-binding peptides targeting the C-terminus region of the EBV oncoprotein. Peptides 85, pages 73-79.
Crossref

D. Topalis, S. Gillemot, R. Snoeck & G. Andrei. (2016) Distribution and effects of amino acid changes in drug-resistant α and β herpesviruses DNA polymerase. Nucleic Acids Research, pages gkw875.
Crossref

Fenggang Yu, Wei Jian Tan, Yanan Lu, Paul A. MacAry & Kwok Seng Loh. (2016) The other side of the coin: Leveraging Epstein–Barr virus in research and therapy. Oral Oncology 60, pages 112-117.
Crossref

Jingchen Lu, Min Tang, Hongde Li, Zhijie Xu, Xinxian Weng, Jiangjiang Li, Xinfang Yu, Luqing Zhao, Hongwei Liu, Yongbin Hu, Zheqiong Tan, Lifang Yang, Meizuo Zhong, Jian Zhou, Jia Fan, Ann M. Bode, Wei Yi, Jinghe Gao, Lunquan Sun & Ya Cao. (2016) EBV-LMP1 suppresses the DNA damage response through DNA-PK/AMPK signaling to promote radioresistance in nasopharyngeal carcinoma. Cancer Letters 380:1, pages 191-200.
Crossref

Lili Bao, Mingming Tang, Qicheng Zhang, Bo You, Ying Shan, Si Shi, Li Li, Songqun Hu & Yiwen You. (2016) Elevated expression of CD93 promotes angiogenesis and tumor growth in nasopharyngeal carcinoma. Biochemical and Biophysical Research Communications 476:4, pages 467-474.
Crossref

Hengmin Tao, Yumei Wei, Congan Wang, Kun Yang, Wei Huang, Haitao Liu & Baosheng Li. (2015) Expression of chemokine receptor CXCR4 is closely correlated with clinical outcome in human nasopharyngeal carcinoma. Tumor Biology 37:5, pages 6099-6105.
Crossref

Andrea Risso, Cesare Zoia, Carlo Gianformaggio, Fabio Pagella, Alessandro Pusateri, Marco Benazzo & Paolo Gaetani. (2016) Tension pneumocephalus secondary to osteoradionecrosis of the clivus. Reports of Practical Oncology & Radiotherapy 21:1, pages 71-75.
Crossref

Paul W. Ewald & Holly A. Swain Ewald. 2016. Evolutionary Thinking in Medicine. Evolutionary Thinking in Medicine 191 207 .

Jeff P. BruceKenneth YipScott V. BratmanEmma ItoFei-Fei Liu. (2015) Nasopharyngeal Cancer: Molecular Landscape. Journal of Clinical Oncology 33:29, pages 3346-3355.
Crossref

Sharon D. Stoker, Zlata Novalić, Maarten A. Wildeman, Alwin D. R. Huitema, Sandra A. W. M. Verkuijlen, Hedy Juwana, Astrid E. Greijer, I. Bing Tan, Jaap M. Middeldorp & Jan Paul de Boer. (2015) Epstein–Barr virus-targeted therapy in nasopharyngeal carcinoma. Journal of Cancer Research and Clinical Oncology 141:10, pages 1845-1857.
Crossref

Shi-Geng Pei, Ju-Xiang Wang, Xue-Ling Wang, Qing-Jun Zhang & Hong Zhang. (2015) Correlation of survivin, p53 and Ki-67 in laryngeal cancer Hep-2 cell proliferation and invasion. Asian Pacific Journal of Tropical Medicine 8:8, pages 636-642.
Crossref

Charles D. Sturgis, Brian B. Burkey, Suhael Momin & Aaron P. Hoschar. (2015) High Grade (Large Cell) Neuroendocrine Carcinoma of the Nasopharynx: Novel Case Report with Touch Preparation Cytology and Positive EBV Encoded Early RNA. Case Reports in Pathology 2015, pages 1-4.
Crossref

Francesco Perri, Giuseppina Della Vittoria Scarpati & Mario Giuliano. 2015. International Manual of Oncology Practice. International Manual of Oncology Practice 605 627 .

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Therapeutic implications of Epstein–Barr virus infection for the treatment of nasopharyngeal carcinoma

Articles from other publishers (36)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Therapeutic implications of Epstein–Barr virus infection for the treatment of nasopharyngeal carcinoma

Citations (36)

Articles from other publishers (36)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date